FDA Drug recall D-0650-2017
Quinapril Tablets USP 5 mg, 90 count bottles, Lupin Pharmaceuticals, Inc., Baltimore, MD --- NDC 68180-556-09
- FDA Drug
- Class III
- terminated
- Published 2017-04-12
On 2017-04-12 the FDA classified a Class III recall of Quinapril Tablets USP 5 mg, 90 count bottles, Lupin Pharmaceuticals, Inc., Baltimore, MD --- NDC 68180-556-09 by Lupin Pharmaceuticals, citing failed Impurities/Degradation Specifications; Impurity A.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0650-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2015-12-07 |
| Published | 2017-04-12 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Lupin Pharmaceuticals |
| Distribution | US |
Product
Quinapril Tablets USP 5 mg, 90 count bottles, Lupin Pharmaceuticals, Inc., Baltimore, MD --- NDC 68180-556-09
Reason
Failed Impurities/Degradation Specifications; Impurity A
Identifiers
| ndc | 68180-556-09 |
|---|---|
| ndc | 68180-557-09 |
| ndc | 68180-557-03 |
| ndc | 68180-558-09 |
| ndc | 68180-558-03 |
| ndc | 68180-554-09 |
| ndc | 68180-554-03 |
| ndc | 68180-559-03 |
| ndc | 68180-559-09 |
| code_info | Batch number G303703, exp 3/2016 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0650-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.